South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 620.71 billion. The enterprise value is 698.38 billion.
| Market Cap | 620.71B |
| Enterprise Value | 698.38B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 13.56% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +13.56% |
| Shares Change (QoQ) | -14.67% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.62% |
| Float | 20.60M |
Valuation Ratios
The trailing PE ratio is 17.32.
| PE Ratio | 17.32 |
| Forward PE | n/a |
| PS Ratio | 1.08 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | 165.23 |
| P/OCF Ratio | 35.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.45, with an EV/FCF ratio of 185.91.
| EV / Earnings | 20.01 |
| EV / Sales | 1.22 |
| EV / EBITDA | 15.45 |
| EV / EBIT | 30.43 |
| EV / FCF | 185.91 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.04 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.98 |
| Debt / FCF | 35.58 |
| Interest Coverage | 2.21 |
Financial Efficiency
Return on equity (ROE) is 14.65% and return on invested capital (ROIC) is 5.33%.
| Return on Equity (ROE) | 14.65% |
| Return on Assets (ROA) | 2.48% |
| Return on Invested Capital (ROIC) | 5.33% |
| Return on Capital Employed (ROCE) | 6.46% |
| Weighted Average Cost of Capital (WACC) | 8.23% |
| Revenue Per Employee | 540.01M |
| Profits Per Employee | 32.90M |
| Employee Count | 1,061 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 3.49 |
Taxes
In the past 12 months, KRX:249420 has paid 9.25 billion in taxes.
| Income Tax | 9.25B |
| Effective Tax Rate | 23.22% |
Stock Price Statistics
The stock price has increased by +43.54% in the last 52 weeks. The beta is 0.82, so KRX:249420's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +43.54% |
| 50-Day Moving Average | 25,272.60 |
| 200-Day Moving Average | 29,311.75 |
| Relative Strength Index (RSI) | 23.37 |
| Average Volume (20 Days) | 267,136 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 572.95 billion and earned 34.91 billion in profits. Earnings per share was 1,137.36.
| Revenue | 572.95B |
| Gross Profit | 227.65B |
| Operating Income | 22.57B |
| Pretax Income | 39.82B |
| Net Income | 34.91B |
| EBITDA | 44.83B |
| EBIT | 22.57B |
| Earnings Per Share (EPS) | 1,137.36 |
Balance Sheet
The company has 59.07 billion in cash and 133.65 billion in debt, with a net cash position of -74.58 billion or -2,366.89 per share.
| Cash & Cash Equivalents | 59.07B |
| Total Debt | 133.65B |
| Net Cash | -74.58B |
| Net Cash Per Share | -2,366.89 |
| Equity (Book Value) | 250.86B |
| Book Value Per Share | 7,850.49 |
| Working Capital | 9.27B |
Cash Flow
In the last 12 months, operating cash flow was 17.33 billion and capital expenditures -13.57 billion, giving a free cash flow of 3.76 billion.
| Operating Cash Flow | 17.33B |
| Capital Expenditures | -13.57B |
| Depreciation & Amortization | 22.26B |
| Net Borrowing | -32.49B |
| Free Cash Flow | 3.76B |
| FCF Per Share | 119.23 |
Margins
Gross margin is 39.73%, with operating and profit margins of 3.94% and 6.09%.
| Gross Margin | 39.73% |
| Operating Margin | 3.94% |
| Pretax Margin | 6.95% |
| Profit Margin | 6.09% |
| EBITDA Margin | 7.82% |
| EBIT Margin | 3.94% |
| FCF Margin | 0.66% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.02%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 0.17% |
| Buyback Yield | -13.56% |
| Shareholder Yield | -12.55% |
| Earnings Yield | 5.62% |
| FCF Yield | 0.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 2.91 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.91 |
| Piotroski F-Score | 6 |